The impact of hemostasis type in endometrioma surgery on the ovarian reserve

Phase 3

Completed

• Conditions: ovarian endometrioma; endometrioma

• Registration Number: TCTR20140212003
• Lead Sponsor: Faculty of Medicine ,Thammasat University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2014-01-11
• Study Start: 2014-02-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Reproductive women , age 18- 45 years who undergo laparoscopic ovarian cystectomy whom meet the following eligible criteria
•Participants must be between the ages of 18 – 45 during enter the study .
•Every participants have to completely understand the process of this study and have written informed consent .
•Having regular menstrual cycles (21–35 days) at the time of operation
•no evidence of any other endocrine disorders such as diabetes mellitus, thyroid dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, Cushing's syndrome, or adrenal insufficiency.
•undergo laparoscopic ovarian cystectomy
•pathological diagnosis of excised ovarian tissue confirm as endometriotic cyst
•No previous history of adnexal surgery
•No any suspicious findings of malignant ovarian diseases
•Never taking any medication such as oral pill and hormonal drugs within 3 months before the enrollment.

Exclusion Criteria

-polycystic ovarian syndrome according to the Rotterdam criteria
-pathological diagnosis of excised ovarian tissue confirm as non-endometriotic cyst
-Conversion to laparotomy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ovarian reserve 6 months after intervention anti-müllerian hormone

Secondary Outcome Measures

Name	Time	Method
ovarian reserve 1 week , 1,3 months after intervention anti-müllerian hormone